X

Indication

Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia... read more

Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia due to chronic kidney disease (CKD), including patients on dialysis and patients not on dialysis. read more

Aranesp® (darbepoetin alfa) is indicated for the treatment of anemia due to chronic kidney disease (CKD), including patients on dialysis and patients not on dialysis.

Limitations of Use

  • Aranesp® has not been shown to improve quality of life, fatigue, or patient well-being.
  • Aranesp® is not indicated for use as a substitute for red blood cell transfusions in patients who require immediate correction of anemia.
› Email› Print

Aranesp® offers multiple dosing and administration options


QW and Q2W dosing for patients on HD and PD

Patients with CKD on Dialysis*

*The intravenous route is recommended for patients on hemodialysis.

  • Prefilled syringe may reduce the potential for dosing errors.1
  • UltraSafe Needle Guard is designed to protect from unintentional needlesticks.2

Q4W for patients not on dialysis

For Patients with CKD Not on Dialysis

Aranesp® is administered Q4W intravenously or subcutaneously as appropriate.

Important Safety Information

  • Control hypertension prior to initiating and during treatment with Aranesp®.
  • Aranesp® increases the risk of seizures in patients with CKD. Monitor patients closely for new-onset seizures, premonitory symptoms, or change in seizure frequency.

Scroll down for additional Important Safety Information

Abbreviations and References:
CKD = chronic kidney disease; HD = hemodialysis; PD = peritoneal dialysis; QW = once weekly; Q2W = once every 2 weeks; Q4W = once every 4 weeks; TIW = three times a week.
UltraSafe® is a registered trademark of Safety Syringes, Inc.
References: 1. Detournay B, Aden G, Fabregas X, Lattarulo M, Lebouvier G. Prefilled disposable syringes vs conventional injection systems: European medicoeconomic analysis. EHP. 1998;4(4):109-113. 2. UltraSafe® Needle Guards [brochure]. Carlsbad, CA: Safety Syringes, Inc.; 2007. http://www.safetysyringes.com/pdf/25-NG_English2007cfo.pdf. Accessed December 4, 2014.